403 related articles for article (PubMed ID: 12137728)
1. Tacrolimus ointment: a new therapy for atopic dermatitis--review of the literature.
Pustisek N; Lipozencić J; Ljubojević S
Acta Dermatovenerol Croat; 2002 Mar; 10(1):25-32. PubMed ID: 12137728
[TBL] [Abstract][Full Text] [Related]
2. Tacrolimus ointment (Protopic) for atopic dermatitis.
Pascual JC; Fleisher AB
Skin Therapy Lett; 2004 Nov; 9(9):1-5. PubMed ID: 15550992
[TBL] [Abstract][Full Text] [Related]
3. Efficacy and safety of tacrolimus ointment in pediatric Patients with moderate to severe atopic dermatitis.
Singalavanija S; Noppakun N; Limpongsanuruk W; Wisuthsarewong W; Aunhachoke K; Chunharas A; Wananukul S; Akaraphanth R
J Med Assoc Thai; 2006 Nov; 89(11):1915-22. PubMed ID: 17205874
[TBL] [Abstract][Full Text] [Related]
4. Tacrolimus ointment 0.03% is safe and effective for the treatment of mild to moderate atopic dermatitis in pediatric patients: results from a randomized, double-blind, vehicle-controlled study.
Schachner LA; Lamerson C; Sheehan MP; Boguniewicz M; Mosser J; Raimer S; Shull T; Jaracz E;
Pediatrics; 2005 Sep; 116(3):e334-42. PubMed ID: 16140675
[TBL] [Abstract][Full Text] [Related]
5. A 4-year follow-up study of atopic dermatitis therapy with 0.1% tacrolimus ointment in children and adult patients.
Reitamo S; Rustin M; Harper J; Kalimo K; Rubins A; Cambazard F; Brenninkmeijer EE; Smith C; Berth-Jones J; Ruzicka T; Sharpe G; Taieb A;
Br J Dermatol; 2008 Sep; 159(4):942-51. PubMed ID: 18637898
[TBL] [Abstract][Full Text] [Related]
6. Atopic dermatitis management with tacrolimus ointment (Protopic).
Kapp A; Allen BR; Reitamo S
J Dermatolog Treat; 2003; 14(Suppl 1):5-16. PubMed ID: 14522634
[TBL] [Abstract][Full Text] [Related]
7. Superiority of tacrolimus 0.1% ointment compared with fluticasone 0.005% in adults with moderate to severe atopic dermatitis of the face: results from a randomized, double-blind trial.
Doss N; Reitamo S; Dubertret L; Fekete GL; Kamoun MR; Lahfa M; Ortonne JP
Br J Dermatol; 2009 Aug; 161(2):427-34. PubMed ID: 19416227
[TBL] [Abstract][Full Text] [Related]
8. Skin and systemic pharmacokinetics of tacrolimus following topical application of tacrolimus ointment in adults with moderate to severe atopic dermatitis.
Undre NA; Moloney FJ; Ahmadi S; Stevenson P; Murphy GM
Br J Dermatol; 2009 Mar; 160(3):665-9. PubMed ID: 19076975
[TBL] [Abstract][Full Text] [Related]
9. Long-term safety and efficacy of tacrolimus ointment for the treatment of atopic dermatitis in children.
Remitz A; Harper J; Rustin M; Goldschmidt WF; Palatsi R; van der Valk PG; Sharpe G; Smith CH; Dobozy A; Turjanmaa K;
Acta Derm Venereol; 2007; 87(1):54-61. PubMed ID: 17225017
[TBL] [Abstract][Full Text] [Related]
10. 0.03% Tacrolimus ointment applied once or twice daily is more efficacious than 1% hydrocortisone acetate in children with moderate to severe atopic dermatitis: results of a randomized double-blind controlled trial.
Reitamo S; Harper J; Bos JD; Cambazard F; Bruijnzeel-Koomen C; Valk P; Smith C; Moss C; Dobozy A; Palatsi R;
Br J Dermatol; 2004 Mar; 150(3):554-62. PubMed ID: 15030341
[TBL] [Abstract][Full Text] [Related]
11. A multicentre, randomized, double-blind, controlled study of long-term treatment with 0.1% tacrolimus ointment in adults with moderate to severe atopic dermatitis.
Reitamo S; Ortonne JP; Sand C; Cambazard F; Bieber T; Fölster-Holst R; Vena G; Bos JD; Fabbri P; Groenhoej Larsen C;
Br J Dermatol; 2005 Jun; 152(6):1282-9. PubMed ID: 15948994
[TBL] [Abstract][Full Text] [Related]
12. Effect of sequential applications of topical tacrolimus and topical corticosteroids in the treatment of pediatric atopic dermatitis: an open-label pilot study.
Kubota Y; Yoneda K; Nakai K; Katsuura J; Moriue T; Matsuoka Y; Miyamoto I; Ohya Y
J Am Acad Dermatol; 2009 Feb; 60(2):212-7. PubMed ID: 19027990
[TBL] [Abstract][Full Text] [Related]
13. The role of topical calcineurin inhibitors in atopic dermatitis.
Alomar A; Berth-Jones J; Bos JD; Giannetti A; Reitamo S; Ruzicka T; Stalder JF; Thestrup-Pedersen K;
Br J Dermatol; 2004 Dec; 151 Suppl 70 Dec 2004():3-27. PubMed ID: 15548171
[TBL] [Abstract][Full Text] [Related]
14. A short-term trial of tacrolimus ointment for atopic dermatitis. European Tacrolimus Multicenter Atopic Dermatitis Study Group.
Ruzicka T; Bieber T; Schöpf E; Rubins A; Dobozy A; Bos JD; Jablonska S; Ahmed I; Thestrup-Pedersen K; Daniel F; Finzi A; Reitamo S
N Engl J Med; 1997 Sep; 337(12):816-21. PubMed ID: 9295241
[TBL] [Abstract][Full Text] [Related]
15. The safety of tacrolimus ointment for the treatment of atopic dermatitis: a review.
Rustin MH
Br J Dermatol; 2007 Nov; 157(5):861-73. PubMed ID: 17854353
[TBL] [Abstract][Full Text] [Related]
16. Tacrolimus ointment: new preparation. Too many unknowns.
Prescrire Int; 2004 Jun; 13(71):86-9. PubMed ID: 15233141
[TBL] [Abstract][Full Text] [Related]
17. The pharmacokinetics of tacrolimus after first and repeated dosing with 0.03% ointment in infants with atopic dermatitis.
Reitamo S; Mandelin J; Rubins A; Remitz A; Mäkelä M; Cirule K; Rubins S; Zigure S; Ho V; Dickinson J; Undre N
Int J Dermatol; 2009 Apr; 48(4):348-55. PubMed ID: 19335418
[TBL] [Abstract][Full Text] [Related]
18. Tacrolimus ointment. A review of its therapeutic potential as a topical therapy in atopic dermatitis.
Cheer SM; Plosker GL
Am J Clin Dermatol; 2001; 2(6):389-406. PubMed ID: 11770393
[TBL] [Abstract][Full Text] [Related]
19. Pimecrolimus in dermatology: atopic dermatitis and beyond.
Gisondi P; Ellis CN; Girolomoni G
Int J Clin Pract; 2005 Aug; 59(8):969-74. PubMed ID: 16033622
[TBL] [Abstract][Full Text] [Related]
20. Reduced dermal infiltration of cytokine-expressing inflammatory cells in atopic dermatitis after short-term topical tacrolimus treatment.
Simon D; Vassina E; Yousefi S; Kozlowski E; Braathen LR; Simon HU
J Allergy Clin Immunol; 2004 Oct; 114(4):887-95. PubMed ID: 15480330
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]